•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

L&L advises Symbiotec pharma in PE acquisition by InvAscent, Motilal Oswal

“A consortium of mid-market private equity firms InvAscent and Motilal Oswal PE has bought British PE firm Actis’ entire stake of around 70% in bulk-drugs maker Symbiotec Pharmalab Pvt. Ltd,” reported VCCircle.

L&L Partners advised the promoters of Symbiotec, according to IBLJ, led by partner William Vivian John with managing associate Deepak Kumar and associate Tanaya Sanyal.


No comments yet: share your views

Latest comments